Co-Authors
This is a "connection" page, showing publications co-authored by Mitra Rezaei and Hamidreza Jamaati.
Connection Strength
0.174
-
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107961.
Score: 0.060
-
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407.
Score: 0.058
-
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos. 2020 Nov; 19(2):91-99.
Score: 0.057